Pharmaceutical Analysis of Eptifibatide via Simple, Rapid, Economical UV-Spectrophotometric Methods

Abstract

Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Pharmaceutically it is applied to reduce the risk of acute cardiac ischemic events. The present work reveals two simple, rapid and economical UuV-Spectrophotometric methods for pharmaceutical analysis of Eeptifibatide bulk and in parenteral formulation. The ‘Method I’ is based on the Zero Order Spectrophotometric determination of drug at its wavelength maximum 218.20 nm and ‘Method II’ employed First Order Derivative - Aarea Uunder Curve (AUauC) technique in which the area has been integrated between two wavelengths 220.20 to 237.20 nm. The drug obeyed linearity in the concentration range of 3 - 18 μg/mLl with coefficient of correlation; greater than 0.999 in both methods. The amounts of drug determined by both methods are in conformity with label claim. These methods are validated for accuracy, precision and ruggedness with % RSD value less than 2.0.

  • Page Number : 49-55
  • Keywords
    Eptifibatide, UV-Spectrophotometry, First Order Derivative-AUC
  • DOI Number
    10.15415/jptrm.2015.31004
  • Authors
    • Sushant S. Patil R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India
    • Saurabh B. Ganorkar R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India
    • Atul A. Shirkhedkar R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, India

References

  • Hantgan, R., Rocco, M., Nagaswami, C., Weisel, J., et al. (2001), Binding of a fibrinogen mimetic stabilizes integrin αIIbβ3’s open conformotion, Protein Science, 10(8), 1614-1626. http://dx.doi.org/10.1110/ps.3001
  • ICH Harmonized Tripartite Guideline, Q2 (R1): Validation of Analytical Procedures: Text and Methodology. November 2005.
  • Kachhadia, P., (2008), Studies on synthesis of bioactive compounds and HPLC profile of some pharmaceutical formulation, thesis PhD, Saurashtra University, Rajkot, India.
  • Katori, N., Szlam, F., Levy, S., Tanaka, K., et al. (2004), A novel method to assess platelet inhibition by Eptifibatide with Thrombelastograph, Anesthesia & Analgesia, 99(6), 1794-1799. http://dx.doi.org/10.1213/01.ANE.0000136476.82598.88
  • Liu, Z., Duan, X., Chen, X., Zhong, D., et al (2009), Determination of Eptifibatide concentration in human plasma utilizing the liquid chromatography-tandem mass spectrometry method, Journal of chromatography B, 877( 5-6), 527-532.
  • The Merck Index – An Encyclopedia of Chemicals, Drugs and Biologicals, 14th edn, Merck Research Laboratories, Whitehouse Station, New Jersey, USA, 2006, 6247.
  • Yu, X., Zhou, Z., Yang, M., Mai, L., Lin, Q., Deng, C., Shan, Z., Kuang, S., Zhu, P., Huang, X., Li, X., Chen, T., Lin, S., (2010), Improved liquid chromatography-tandem mass spectrometry method for the analysis of Eptifibatide in human plasma, Journal of chromatography B, 878(23), 2094-2100. http://dx.doi.org/10.1016/j.jchromb.2010.06.012

  • Published Date : 2015-05-20